|
Re: AGM - Jan 7, 2016 - Details
|
2
|
Zenith Epigenetics
|
Jan 13, 2016 10:23AM
|
|
Re: Upcoming Resverlogix and Zenith Events
|
3
|
Resverlogix Corp.
|
Jan 13, 2016 01:47PM
|
|
Re: Zenith Meeting now posted
|
|
Resverlogix Corp.
|
Jan 15, 2016 11:36AM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Jan 15, 2016 11:53AM
|
|
Zenith AGM Presentation now posted on Zenith website
|
5
|
Zenith Epigenetics
|
Jan 15, 2016 08:18PM
|
|
Re: Zenith AGM Presentation now posted on Zenith website
|
5
|
Zenith Epigenetics
|
Jan 16, 2016 11:16AM
|
|
Re: I just put up a new blog post on Seeking Alpha....
|
5
|
Resverlogix Corp.
|
Jan 16, 2016 11:29AM
|
|
Re: Zenith AGM Presentation now posted on Zenith website
|
1
|
Zenith Epigenetics
|
Jan 17, 2016 09:45PM
|
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
3
|
Resverlogix Corp.
|
Jan 17, 2016 09:54PM
|
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
8
|
Resverlogix Corp.
|
Jan 18, 2016 01:35PM
|
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
10
|
Resverlogix Corp.
|
Jan 18, 2016 06:22PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
4
|
Resverlogix Corp.
|
Jan 19, 2016 04:07PM
|
|
Re: Zacks new analyst research update price increase and buy rating
|
6
|
Resverlogix Corp.
|
Jan 19, 2016 05:04PM
|
|
Any catalysts in Q1 to awaken the masses?
|
5
|
Resverlogix Corp.
|
Jan 19, 2016 09:55PM
|
|
Re: FYI... first quarter RVX events section...
|
5
|
Resverlogix Corp.
|
Jan 21, 2016 01:59PM
|
|
New RVX Publication in Atherosclerosis
|
12
|
Resverlogix Corp.
|
Jan 23, 2016 11:07PM
|
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 23, 2016 11:24PM
|
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 24, 2016 04:04PM
|
|
Re: A little surprised there was no PR about the article.....
|
6
|
Resverlogix Corp.
|
Jan 25, 2016 11:58AM
|
|
Resverlogix's Manuscript on RVX-208 Accepted into the Atherosclerosis Journal
|
2
|
Resverlogix Corp.
|
Jan 25, 2016 01:51PM
|
